Anticonvulsant activity of nitrobenzamides and their inhibition of nicotinamide-adenine dinucleotide dependent oxidations.
D000577:Amides / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D001565:Benzoates / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D005260:Female; D008297:Male; D051379:Mice; D009207:Myoclonus / Q000188:drug therapy / Q000517:prevention & control; D009243:NAD / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009574:Nitro Compounds / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats
D000577:Amides; D000927:Anticonvulsants; D001565:Benzoates; D009574:Nitro Compounds; D009243:NAD; D010433:Pentylenetetrazole